Targeting the stroma in pancreatic cancer

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The tumor stroma in pancreatic adenocarcinoma is recognized as an integral component in tumorigenesis through its effects on cell signaling, immunosuppression and inhibitory effect on therapeutic agents. Promising preclinical activity has been observed with novel therapeutic agents that target the tumor microenvironment and represent one of many potential treatment strategies of interest in this disease. Herein, we will highlight and review therapeutic novel agents aimed at tumor stroma in pancreas cancer.

Original languageEnglish (US)
Article number65
JournalChinese Clinical Oncology
Volume6
Issue number6
DOIs
StatePublished - Dec 1 2017

Fingerprint

Pancreatic Neoplasms
Tumor Microenvironment
Therapeutic Uses
Immunosuppression
Neoplasms
Carcinogenesis
Adenocarcinoma
Therapeutics

Keywords

  • Immunotherapy
  • Microenvironment
  • Pancreatic cancer
  • Stroma
  • Targeted therapies

ASJC Scopus subject areas

  • Oncology

Cite this

Targeting the stroma in pancreatic cancer. / Ahn, Daniel; Ramanathan, Ramesk K.

In: Chinese Clinical Oncology, Vol. 6, No. 6, 65, 01.12.2017.

Research output: Contribution to journalReview article

@article{47b4d043f3214a2cb0c9216bf527827d,
title = "Targeting the stroma in pancreatic cancer",
abstract = "The tumor stroma in pancreatic adenocarcinoma is recognized as an integral component in tumorigenesis through its effects on cell signaling, immunosuppression and inhibitory effect on therapeutic agents. Promising preclinical activity has been observed with novel therapeutic agents that target the tumor microenvironment and represent one of many potential treatment strategies of interest in this disease. Herein, we will highlight and review therapeutic novel agents aimed at tumor stroma in pancreas cancer.",
keywords = "Immunotherapy, Microenvironment, Pancreatic cancer, Stroma, Targeted therapies",
author = "Daniel Ahn and Ramanathan, {Ramesk K}",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/cco.2017.11.02",
language = "English (US)",
volume = "6",
journal = "Chinese Clinical Oncology",
issn = "2304-3865",
publisher = "Society for Translational Medicine (STM)",
number = "6",

}

TY - JOUR

T1 - Targeting the stroma in pancreatic cancer

AU - Ahn, Daniel

AU - Ramanathan, Ramesk K

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The tumor stroma in pancreatic adenocarcinoma is recognized as an integral component in tumorigenesis through its effects on cell signaling, immunosuppression and inhibitory effect on therapeutic agents. Promising preclinical activity has been observed with novel therapeutic agents that target the tumor microenvironment and represent one of many potential treatment strategies of interest in this disease. Herein, we will highlight and review therapeutic novel agents aimed at tumor stroma in pancreas cancer.

AB - The tumor stroma in pancreatic adenocarcinoma is recognized as an integral component in tumorigenesis through its effects on cell signaling, immunosuppression and inhibitory effect on therapeutic agents. Promising preclinical activity has been observed with novel therapeutic agents that target the tumor microenvironment and represent one of many potential treatment strategies of interest in this disease. Herein, we will highlight and review therapeutic novel agents aimed at tumor stroma in pancreas cancer.

KW - Immunotherapy

KW - Microenvironment

KW - Pancreatic cancer

KW - Stroma

KW - Targeted therapies

UR - http://www.scopus.com/inward/record.url?scp=85039759428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039759428&partnerID=8YFLogxK

U2 - 10.21037/cco.2017.11.02

DO - 10.21037/cco.2017.11.02

M3 - Review article

C2 - 29307204

AN - SCOPUS:85039759428

VL - 6

JO - Chinese Clinical Oncology

JF - Chinese Clinical Oncology

SN - 2304-3865

IS - 6

M1 - 65

ER -